Intravenous infusion (IV) for initial dosage; Injection for maintenance therapy
Moderate to severe Crohn's disease, and ulcerative colitis
Recommendations for Pregnancy
Limited human data; No adverse effects or risks in animal studies
Recommendations for Lactation
No human data
Indicated for the treatment of adults with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy Also indicated for the treatment of adult patients with moderately to severely active ulcerative colitis.
Indicated for pediatric use
Most common side effects
Common side effects include upper respiratory infections, headache, tiredness, itching, vomiting, vaginal yeast infections, urinary tract infections, redness at the injection site
Rare side effects include reversible posterior leukoencephalopathy syndrome (this is a reversible syndrome that can include headache, altered mental functioning, seizures, and loss of vision).
To see the full prescribing information for this medication, click here.
Scroll right by clicking & dragging with your cursor or swiping with your finger.